SBRA — Sabra Health Care REIT Share Price
- $4.14bn
- $6.50bn
- $703.24m
- 68
- 51
- 70
- 67
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | 23.89 | ||
PEG Ratio (f) | 1.91 | ||
EPS Growth (f) | 14.33% | ||
Dividend Yield (f) | 7.01% |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 1.51 | ||
Price to Tang. Book | 1.53 | ||
Price to Free Cashflow | 23.8 | ||
Price to Sales | 5.89 | ||
EV to EBITDA | 15.93 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 2.32% | ||
Return on Equity | 4.57% | ||
Operating Margin | 17.53% |
Financial Summary
Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | 596.77 | 569.04 | 624.71 | 647.51 | 703.24 | 728.63 | 765.45 | 3.4% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | -1.76 | n/a | n/a | n/a | +49.19 | +16.73 | +9.9 | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Sabra Health Care REIT, Inc. operates as a self-administered, self-managed real estate investment trust that, through its subsidiaries, owns and invests in real estate serving the healthcare industry throughout the United States and Canada. Its primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector. Its investment portfolio primarily comprises skilled nursing/transitional care facilities, senior housing communities (Senior Housing - Leased), behavioral health facilities, and specialty hospitals and other facilities, in each case leased to third-party operators; senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing - Managed); investments in joint ventures; loans receivable, and preferred equity investments. Its real estate properties held for investment included 37,047 beds/units, spread across the United States and Canada.
Directors
- Richard Matros CHM (67)
- Michael Costa CFO (43)
- Talya Nevo-Hacohen EVP (61)
- Michael Foster LED (67)
- Craig Barbarosh IND (53)
- Katie Cusack IND (54)
- Lynne Katzmann IND (64)
- Ann Kono IND (45)
- Jeffrey Malehorn IND (60)
- Clifton Porter IND (54)
- Milton Walters IND (78)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- May 10th, 2010
- Public Since
- November 6th, 2010
- No. of Shareholders
- 3,797
- No. of Employees
- 50
- Sector
- Residential & Commercial REITs
- Industry
- Financials
- Exchange
NASDAQ Global Select Market
- Shares in Issue
- 237,910,973

- Address
- 1781 FLIGHT WAY, TUSTIN, 92782
- Web
- https://sabrahealth.com/
- Phone
- +1 8883938248
- Auditors
- PricewaterhouseCoopers LLP
Upcoming Events for SBRA
Q1 2025 Sabra Health Care REIT Inc Earnings Call
Sabra Health Care REIT Inc Annual Shareholders Meeting
Sabra Health Care REIT Inc Annual Shareholders Meeting
Q2 2025 Sabra Health Care REIT Inc Earnings Release
Similar to SBRA
Agnc Investment
NASDAQ Global Select Market
Diversified Healthcare Trust
NASDAQ Global Select Market
Equinix
NASDAQ Global Select Market
Gaming and Leisure Properties
NASDAQ Global Select Market
Gladstone Commercial
NASDAQ Global Select Market
FAQ
As of Today at 23:01 UTC, shares in Sabra Health Care REIT are trading at $17.42. This share price information is delayed by 15 minutes.
Shares in Sabra Health Care REIT last closed at $17.42 and the price had moved by +27.62% over the past 365 days. In terms of relative price strength the Sabra Health Care REIT share price has outperformed the S&P500 Index by +17.8% over the past year.
The overall consensus recommendation for Sabra Health Care REIT is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe Sabra Health Care REIT dividend yield is 6.89% based on the trailing twelve month period.
Last year, Sabra Health Care REIT paid a total dividend of $1.20, and it currently has a trailing dividend yield of 6.89%. We do not have any data on when Sabra Health Care REIT is to next pay dividends.
We do not have data on when Sabra Health Care REIT is to next pay dividends. The historic dividend yield on Sabra Health Care REIT shares is currently 6.89%.
To buy shares in Sabra Health Care REIT you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $17.42, shares in Sabra Health Care REIT had a market capitalisation of $4.14bn.
Here are the trading details for Sabra Health Care REIT:
- Country of listing: United States
- Exchange: NSQ
- Ticker Symbol: SBRA
Based on an overall assessment of its quality, value and momentum Sabra Health Care REIT is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Sabra Health Care REIT is $19.50. That is 11.94% above the last closing price of $17.42.
Analysts covering Sabra Health Care REIT currently have a consensus Earnings Per Share (EPS) forecast of $0.71 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Sabra Health Care REIT. Over the past six months, its share price has underperformed the S&P500 Index by -2.34%.
As of the last closing price of $17.42, shares in Sabra Health Care REIT were trading +0.07% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Sabra Health Care REIT PE ratio based on its reported earnings over the past 12 months is 23.89. The shares last closed at $17.42.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Sabra Health Care REIT's management team is headed by:
- Richard Matros - CHM
- Michael Costa - CFO
- Talya Nevo-Hacohen - EVP
- Michael Foster - LED
- Craig Barbarosh - IND
- Katie Cusack - IND
- Lynne Katzmann - IND
- Ann Kono - IND
- Jeffrey Malehorn - IND
- Clifton Porter - IND
- Milton Walters - IND